INTRODUCTION
Few studies document the efficacy of utilizing iliac crest autograft with dynamic plates (ABC; Aesculap, Tuttlingen, Germany) for performing single-level anterior cervical diskectomy and fusion (1-ACDF) addressing disc disease/spondylosis or ossification of the posterior longitudinal ligament (OPLL). One-year fusion rates (dynamic X-rays and 2D-CT studies) and 2-year outcomes (Nurick Grades, Odom's Criteria, and Short-Form [SF-36] questionnaires) were assessed for 60 such patients undergoing single-level anterior cervical diskectomy and fusion (1-ACDF) utilizing iliac crest autograft and dynamic plates.
MATERIALS AND METHODS

Clinical Data
Sixty patients, 33 females and 27 males, underwent 1-ACDF utilizing iliac crest autograft and dynamic ABC plates [ Table 1 ]. Thirty-two of these patients had a history of trauma. Thirty of 60 patients demonstrated various comorbidities which included diabetes (3 patients), hypertension (5 patients), psychiatric/anxiety disorders (3 patients) , osteoporosis (5 patients), smoking (12 patients/8 heavy smokers), and obesity (21 patients). The average patient weighed 184 lbs (range 115-320); 21 patients weighed over 200 lbs, and 7 of these weighed over 240 lbs. Preoperative neurological deficits included radiculopathy (18 patients) or myelopathy (42 patients). Prior to surgery, the average Nurick Score was 3.3, consistent with moderate myelopathy (Nurick Grade range II-V).
MR and CT Studies
Preoperatively, both MR and CT studies were obtained to document cervical disc disease/spondylosis (38 patients) or OPLL (22 patients) [ . MR scans uniquely documented increased signals in the cord consistent with edema/myelomalacia (19 patients), while CT studies best delineated OPLL. Three patients had prior 1-ACDF performed at other levels [ Table 1 ]. Single-level ACDF procedures involved the C5-C6 (29 patients), C6-C7 (20 patients), C4-C5 (6 patients), and C3-C4 (5 patients) levels. Single-level ACDF was performed utilizing iliac crest autograft and dynamic plates [ Table  1 ]. The average operative time was 3.4 h [ Table 1 ]. Patients were followed for an average of 4.8 postoperative years (minimum 2-year follow-up).
Documentation of Fusion
Postoperative fusion rates, assessed by two independent neuroradiologists blinded to the study design, were based upon both dynamic X-ray and 2D-CT studies obtained at 3, 4.5, 6, and up to 12 months postoperatively and/or until fusion occurred [ . Dynamic X-ray fusion criteria included the lack of active motion/translation, < 0-1 mm of motion between adjacent spinous processes, and <15° of angulation. 2D-CT fusion criteria included the presence of bony trabeculation, and the lack of lucency at the graft/vertebral body interface. 
Outcome Assessment
Outcomes were analyzed utilizing Nurick Grades, Odom's Criteria, and the SF-36 questionnaires. Nurick Grades and SF-36 questionnaires were assessed preoperatively, and at 3, 6, 12, and 24 months postoperatively, while Odom's Criteria were evaluated over these same intervals but only postoperatively. To simplify the presentation of SF-36 results, data were divided into three categories of "improvement." At each time interval, data were compared with preoperative baselines, e.g., minimal improvement (± 0-5 points), moderate improvement (± 6-10 points), and marked improvement (>10 points).
RESULTS
Outcome Measures
Outcomes were assessed utilizing Nurick Grades/Scores, Odom's Criteria, and SF-36 questionnaires up to 2 years postoperatively. By the second postoperative year, patients improved an average of 3.0 Nurick Grades; the average preoperative Nurick Score was 3.3 (moderate myelopathy), while the mean postoperative Nurick Score was 0.3 (mild radiculopathy) [ Table 2 ]. At two postoperative years, Odom's Criteria revealed 52 excellent, 6 good, 2 fair, and 0 poor outcomes [ Of interest, patients demonstrated the greatest postoperative improvement on the BP health scale by the sixth postoperative week; BP increased from the preoperative baseline of 25.9 to 52.5. Although further increases were observed between 3 months and 2 years postoperatively (56.6 at 3 months, 58.0 at 6 months, 70.5 at 1 year, and 76.7 at 2 years), the largest gains occurred early on (6 weeks; Table 3 ).
Fusion Rates
Utilizing both dynamic X-rays and 2D-CT studies, the average time to fusion was 3.8 months (range 2.5-8 months) [ Table 2 ; . Although pseudarthrosis was not documented, five (8.3%) patients who had been heavy smokers (2 packs/day > 10 years) exhibited delayed fusions occurring between 6 and 8 months postoperatively: three at 6 months, one at 7 months, and one at 8 months respectively. Of note, all five patients remained braced (cervicothoracic orthoses) until fusion was documented on both 2D-CT and dynamic X-ray studies. [7] In the Samartzis et al. series, the fusion rate was 100% for patients undergoing 1-ACDF using fixed plates (Orion; Medtronic) with allograft compared with a 90.3% fusion rate for fixed plate/autograft (note that the difference in fusion rates was not considered significant). [10] In a 1-ACDF study, utilizing dense cancellous allograft and dynamic ABC plates (Aesculap), which utilized a slotted plate design to allow for 10 mm of cephalad/caudad screw migration, a 96% fusion rate was achieved (66 patients). [1] In a prospective randomized study that included 1-ACDF (28 patients) and 2-to 3-level ACDF (38 patients), half of the patients received dynamic plates, while the other half received static plates; the plate type (static versus dynamic) did not impact fusion rates for 1-ACDF, while dynamic plates appeared to contribute (although not significantly) to higher fusion rates for the multilevel group. [9] In this study, utilizing dynamic ABC plates with autograft, a fusion rate of 100% was achieved utilizing both dynamic X-ray and 2D-CT studies. Statistically, there was no significant difference in the fusion rates for this study compared with the others cited.
Outcomes
Typically, comparable outcomes have been reported utilizing varied grafts and/or plating systems for performing 1-ACDF. Good/excellent outcomes were observed in 91.3% of patients undergoing 1-ACDF with (31 patients) or without (38 patients) fixed/ semiconstrained plates. [10] Comparable good/excellent outcomes were achieved: excellent 19.7%, good 71.2%, and fair 9.1%. [10] Although comparable longterm outcomes were also observed following 1-ACDF performed utilizing rhBMP-2 (Medtronic's AMPILFY rhBMP-2 [INFUSE])/ polyetheretherketone (PEEK) cages (Depuy Spine, Raynham, MA, USA), in 22 patients and allograft spacers/demineralized bone matrix (DBM), in 24 patients, the threefold greater cost and incidence of severe postoperative dysphagia (1-6 postoperative weeks) associated with rhBMP-2/PEEK cages prompted the authors to abandon this construct. [11] In another study, comparable was counterbalanced by the shorter operative times and shorter LOS for these constructs compared with autograft/CSLP. [8] In a third 1-ACDF study utilizing cage/ mesh/autograft cancellous bone/plate (27 patients) versus iliac autograft spacer/plate (27 patients), operative costs proved comparable; the operative time saved by avoiding iliac crest bone harvesting was negated by the increased cost of the cage. [4] Two other studies documented that utilizing BMP/INFUSE as a bone graft supplement for 1-ACDF spacers was not cost-effective, as it markedly exacerbated postoperative dysphagia, prolonged the LOS, and increased operative costs. [3, 11] In a separate study, Epstein et al. analyzed instrumentation charges (charges to the insurer by the hospital; not the actual original costs of these items) for performing 102 single-level ACDF performed by 15 different surgeons at a single institution in 2008. [5] All patients had a single diagnosis related group (DRG 473), a single principal procedure code (81.02), and had either myelopathy (22 patients; 722.72) or radiculopathy (80 patients; 722.3) without comorbidities. Instrumentation charges for these 102 patients ranged from $4062 to $40,409, a 10-fold difference in charges (a difference of $36,347; Table 4 ). [5] The instrumentation charge for the author's single patient in that series was the lowest at $4062 for a dynamic plate and four screws accompanied by an autograft. Other surgeons utilized various combinations of plates and spacers (allograft, PEEK, cages), which contributed to the near 10-fold difference in operative charges [ Table 4 ]. [15] 
SUMMARY OF CONTROVERSY
As society focuses on the rising costs of medical care, we as spine surgeons should more actively participate in correlating costs of the different instrumentation systems/constructs with fusion rates and outcomes. The aim of this study was to reaffirm the value of iliac crest autograft and dynamic plates in performing 1-ACDF, a construct which produced more than adequate outcomes and fusion rates but at a lesser cost. Although major economic interests may promote other more expensive plates (constrained [fixed] or semiconstrained) and spacers, the focus should remain on quality of outcomes, fusion rates, and cost containment.
